Maravai LifeSciences Holdings, Inc.
NASDAQ:MRVI
1.98 (USD) • At close May 9, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Omzet
| 259.185 | 288.945 | 883.001 | 799.24 | 284.098 | 143.14 | 123.833 |
| Kosten van de omzet
| 150.876 | 148.743 | 168.957 | 140.561 | 79.649 | 66.849 | 60.765 |
| Brutowinst
| 108.309 | 140.202 | 714.044 | 658.679 | 204.449 | 76.291 | 63.068 |
| Brutowinstmarge
| 0.418 | 0.485 | 0.809 | 0.824 | 0.72 | 0.533 | 0.509 |
| Onderzoek- en ontwikkelingskosten
| 19.221 | 17.28 | 18.369 | 15.219 | 9.304 | 3.627 | 4.499 |
| Algemene en administratieve kosten
| 0 | 0 | 0 | 0 | 0 | 0 | 41.194 |
| Verkoop- en marketingkosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 161.771 | 151.39 | 129.259 | 100.064 | 94.245 | 48.354 | 41.194 |
| Overige kosten
| 162.934 | 3.18 | -0.358 | 0.279 | -7.466 | 0.118 | 0.087 |
| Bedrijfskosten
| 343.926 | 171.85 | 147.628 | 115.283 | 103.549 | 51.981 | 45.693 |
| Bedrijfsresultaat
| -235.617 | -31.648 | 574.216 | 554.645 | 67.597 | 23.988 | 16.436 |
| Bedrijfsresultaat ratio
| -0.909 | -0.11 | 0.65 | 0.694 | 0.238 | 0.168 | 0.133 |
| Totaal overige inkomsten en kosten netto
| -25.865 | 649.384 | -22.744 | -23.88 | -22.085 | -29.841 | -32.934 |
| Inkomen voor belasting
| -261.482 | 617.736 | 551.472 | 530.765 | 81.696 | -5.853 | -16.498 |
| Inkomen voor belasting ratio
| -1.009 | 2.138 | 0.625 | 0.664 | 0.288 | -0.041 | -0.133 |
| Belastingkosten
| -1.86 | 756.111 | 60.809 | 61.515 | 2.88 | -0.652 | 0.417 |
| Nettowinst
| -144.846 | -119.029 | 490.663 | 469.25 | 76.888 | -5.201 | -17.731 |
| Nettowinstmarge
| -0.559 | -0.412 | 0.556 | 0.587 | 0.271 | -0.036 | -0.143 |
| WPA (Winst Per Aandeel)
| -1.05 | -0.9 | 3.73 | 4.09 | 0.8 | -0.054 | -0.2 |
| Verwaterde WPA
| -1.05 | -0.9 | 1.92 | 1.82 | 0.7 | -0.054 | -0.2 |
| EBITDA
| -156.917 | 712.409 | 609.989 | 585.777 | 138.273 | 48.19 | 33.248 |
| EBITDA ratio
| -0.605 | 2.466 | 0.691 | 0.733 | 0.487 | 0.337 | 0.268 |